Monday, November 20, 2017
 
 
Company News: Page (1) of 1 - 09/15/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes
Data Supports Safety and Efficacy of Repatha in Patients With DiabetesSimultaneously Presented at EASD 2017 and Published in The Lancet Diabetes & Endocrinology
(September 15, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Manufacturing,Sales & Marketing,Security,Business Issues,Human Resources,Sales,Human Resources,Sales,England,USA,IT (Information Technology),Security,Medicine,Diet,Disease,healthcare,medical technologists,Pregnancy,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   IBN - Business ,   IBN - ProductivityApps ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines